State Street’s CARGO Therapeutics CRGX Stock Holding History

State Street’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-715,407	Closed	-$2.95M	–	4306
2025 Q2	$2.95M	Buy	715,407 +10,591	+2%	+$45.4K	﹤0.01%	3175
2025 Q1	$2.87M	Sell	704,816 -379,695	-35%	-$2.54M	﹤0.01%	3108
2024 Q4	$15.6M	Buy	1,084,511 +244,650	+29%	+$4.44M	﹤0.01%	2356
2024 Q3	$15.5M	Buy	839,861 +88,000	+12%	+$1.57M	﹤0.01%	2356
2024 Q2	$12.3M	Buy	751,861 +50,443	+7%	+$959K	﹤0.01%	2434
2024 Q1	$15.7M	Buy	701,418 +679,141	+3,049%	+$16.2M	﹤0.01%	2314
2023 Q4	$516K	Buy	+22,277	New	+$378K	﹤0.01%	3635

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State Street's CRGX Position: Q3 2025 in Review

State Street sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 715,407 shares — an estimated $2.95M sold.

State Street first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $15.7M in Q1 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

State Street reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
State Street sold 715,407 CARGO Therapeutics shares in Q3 2025, an estimated $2.95M.
State Street first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
State Street's CARGO Therapeutics position peaked at $15.7M in Q1 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.